Cargando…
Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody
OBJECTIVE: This study aimed to analyze the clinical features of anti-PM/Scl antibodies in Chinese patients. METHOD: We reviewed the clinical data of anti-PM/Scl antibody-positive patients, including their long-term follow-up. RESULTS: A total of 30 patients carried anti-PM/Scl antibodies, 21 (70%) w...
Autores principales: | Ge, Yongpeng, Shu, Xiaoming, He, Linrong, Li, Chunjia, Lu, Xin, Wang, Guochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804089/ https://www.ncbi.nlm.nih.gov/pubmed/35118087 http://dx.doi.org/10.3389/fmed.2021.778211 |
Ejemplares similares
-
Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome
por: Ge, Yongpeng, et al.
Publicado: (2020) -
An Anti-PM/Scl-75 Antibody-positive Japanese Woman Who Developed Inflammatory Myopathy
por: Nakamura, Yuki, et al.
Publicado: (2019) -
Tofacitinib Is an Effective Treatment for Refractory Scleromyositis Associated With Anti-PM/Scl
por: Álvarez Troncoso, Jorge, et al.
Publicado: (2023) -
Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement
por: Shimizu, Tatsuya, et al.
Publicado: (2020) -
Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin
por: Kowalski, Eric H., et al.
Publicado: (2023)